Abstract |
This study examined the therapeutic and prophylactic potential of bacteriophages in a mouse model of Klebsiella pneumoniae lobar pneumonia. Phages were administered intraperitoneally. Liposome-entrapped phages (LP) were effective in treating infection, even when therapy was delayed by 3 days after the induction of pneumonia. In contrast, nonliposomal phages provided protection when administered 24 hours after infection. Administration of nonliposomal phages 6 hours prior to intranasal bacterial challenge resulted in complete protection, compared with LP, which was effective even when administered 48 hours prior to infection. Increased reduction and a greater increment in the levels of proinflammatory and antiinflammatory cytokines, respectively, in homogenates of lung from LP-treated mice were suggestive of increased efficacy of LP in the treatment of pneumonia. This is the first study to assess liposomes as a delivery vehicle for phage, and the results confirm the superiority of LP for both therapeutic and prophylactic applications.
|
Authors | Saloni Singla, Kusum Harjai, Om Prakash Katare, Sanjay Chhibber |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 212
Issue 2
Pg. 325-34
(Jul 15 2015)
ISSN: 1537-6613 [Electronic] United States |
PMID | 25605867
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: [email protected]. |
Chemical References |
- Inflammation Mediators
- Liposomes
|
Topics |
- Animals
- Bacteriophages
(physiology)
- Female
- Inflammation Mediators
(metabolism)
- Klebsiella Infections
(immunology, microbiology, therapy)
- Klebsiella pneumoniae
(virology)
- Liposomes
- Lung
(immunology, metabolism, microbiology)
- Mice, Inbred BALB C
- Nanostructures
(administration & dosage)
- Pneumonia, Bacterial
(immunology, microbiology, therapy)
|